SCHEMBL7140258

SCHEMBL7140258

CO/C=C(/C(=O)O)c1ccccc1C=C/C=C/c1ccccc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LY96 Q9Y6Y9 2/20 0.47
HSD11B1 P28845 1/20 0.43
BCHE P06276 2/20 0.36
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
KMT2A Q03164 1/20 0.35
AR P10275 2/20 0.35
MAOB P27338 1/20 0.35
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.34
TFEB P19484 1/20 0.34
NFE2L2 Q16236 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TRPA1 O75762 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
ALDH1A1 P00352 1/20 0.33
HSP90AA1 P07900 1/20 0.33
ATM Q13315 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140256 1.00 LY96 (0.47) LY96HSD11B1BCHEMEN1USP2
SCHEMBL7135428 0.89 LY96 (0.47) LY96HSD11B1BCHEMEN1USP2
SCHEMBL7139094 0.86 MAOB (0.42) MEN1KMT2AARMAOBLMNA
SCHEMBL7139096 0.86 MAOB (0.42) MEN1KMT2AARMAOBLMNA
SCHEMBL7144515 0.85 KDM1A (0.44) LY96BCHEMEN1KMT2AAR
SCHEMBL7144518 0.85 KDM1A (0.44) LY96BCHEMEN1KMT2AAR
SCHEMBL7140082 0.83 KMT2A (0.34) LY96BCHEMEN1KMT2AAR
SCHEMBL7140079 0.83 KMT2A (0.34) LY96BCHEMEN1KMT2AAR
SCHEMBL7136726 0.81 CAPN1 (0.47) MEN1KMT2AARLMNAMAPT
SCHEMBL7140078 0.81 TUBB4A (0.40) MEN1KMT2AARMAOBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996439-B1 BETA-ALKOXYACRYLATES AGAINST MALARIA HOFFMANN LA ROCHE (CH) 2003-01-08 EP disclosed
US-6084120-A ACTIVE AGAINST CHLOROQUINE-SENSITIVE PATIENTS AND AGAINST CHLOROQUINE-RESISTANT MALARIA PATHOGENS; PROPHYLAXIS AND TREATMENT; E.G., A 3 METHOXY-2-(2-(4-PHENYLBUTA-1,3-DIEN-1-YL)PHENYL)ACRYLIC ACID HOFFMANN-LA ROCHE INC. (US) 2000-07-04 US disclosed